New Delhi, Jan 19 (PTI) Indian Immunologicals on Friday said it has launched the country's first indigenously developed Hepatitis A vaccine.

The vaccine -- Havisure -- represents a significant step forward in the country's fight against Hepatitis A, the company, which is a wholly-owned subsidiary of the National Dairy Development Board (NDDB), said in a statement.

Also Read | Netizens Celebrate Ram Mandir Pran Pratishtha Ceremony Preparations in Ayodhya! Check Out Posts, Pics & Videos Online Capturing the Excitement Leading Up to the Event.

Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.

"Currently Hepatitis A vaccines are imported into the country...Havisure has undergone extensive clinical trials in eight centres and has proven to be safe and efficacious," Indian Immunologicals Ltd (IIL) Managing Director K Anand Kumar said.

Also Read | Ayodhya Dham Junction Railway Station Facts: Know All About New Ayodhya Railway Station That Has Airport-Like Amenities and More.

The vaccine is comparable to the world's leading vaccine sold by multinational companies, he added.

Havisure is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)